Optimizing Patient Recruitment and Engagement Strategies
Engaging the NBCI Model to Ensure Minority Participation
Two cancer drug trials put on hold after patients died, companies say
Two clinical trials have been paused within the past two days because six
participants – including one child – have died, according to reports by the drug
Viewpoint: The Politics of Informed Consent and the Limits of the First Amendment
Physicians are accustomed to disclosing the risks and benefits of treatment as part of their ethical and legal duty to secure informed consent.
Study: Black Americans Live Longer When There Are More Black Doctors In The County
Time and again, it has been stressed that representation matters. Studies have shown it matters in education. It matters in the judicial system. And a new study shows it matters in the medical field.
Treatment of Rare Anemias Shifting Rapidly
A wave of new therapies is starting to reshape the treatment landscape for people with rare anemias, but the authors of a new review also caution that more research is needed to better understand which therapies are right for which patients.
SCDAA, 8 pharma companies team up to increase trial participation
The Sickle Cell Disease Association of America (SCDAA) is collaborating with several pharmaceutical companies in a new initiative aimed at increasing awareness of the blood disorder and promoting clinical trial participation.
NMA Forms Project IMPACT 2.0 Coalition to Increase Minority Participation in Clinical Trials
The National Medical Association (NMA) is launching the formation of the Project IMPACT 2.0 (Increase Minority Participation and Awareness of Clinical Trials) Coalition.